GASTRIC NEWS: The Phase 3 FORTITUDE-101 trial met its primary endpoint of overall survival at a pre-specified interim analysis in people with unresectable locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) cancer with FGFR2b overexpression of ≥10% on tumor cells and who are non-HER2 positive. 🔗 Learn more: https://amgen.ly/3TMYQZZ
About us
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.
- Website
-
http://www.amgen.com
External link for Amgen
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Thousand Oaks, CA
- Type
- Public Company
- Founded
- 1980
- Specialties
- Biologics, Human therapeutics, and Development of novel products
Locations
Employees at Amgen
Updates
-
At Amgen, employees like Amanda are making a big difference in our mission to transform patient lives worldwide. It’s a mission that aligns with her passion to help others—empowering her to advance her career and supporting her peers to do the same. Learn more about how you can make a difference in our team: https://lnkd.in/gCu_CUru
-
At Amgen, the patient voice is central to everything we do. Our Chief Medical Officer, Paul Burton MD PhD FRCP, joined Her Royal Highness Princess Dina Mired for a recent episode of Global Health Dialogues, a podcast presented by OncoDaily, to explore how listening to the patient voice drives better science, deeper compassion, and a more meaningful impact on global health. 🎙️ Don’t miss this powerful conversation – listen now. https://amgen.ly/3Uc6ltF #PatientCentricity #AccessToMedicine #GlobalHealth
Global Health Dialogues with Princess Dina Mired: Amgen's CMO Paul Burton
https://www.youtube.com/
-
En Amgen el bienestar de nuestros colaboradores es muy importante. 👨👩👧👦✨ Por eso, nos alegra que nuestra Campaña de Vacunación Triple Viral MMR II fuera un éxito. 💉 Cada vacuna representa un paso más hacia un ambiente más sano y feliz para todos. ¡Mil gracias a quienes se sumaron a esta iniciativa que regala salud para todos y todas! #SomosAmgen
-
-
-
-
-
+1
-
-
Somos una de las compañías pioneras en biotecnología más grandes del mundo 🌍🧬, y desde 1980 trabajamos todos los días para liberar el potencial de la ciencia hacia soluciones que mejoren la vida de millones de pacientes. 💙🩺 Gracias a más de 27 mil mentes brillantes 💡🌟 en más de 100 países, desarrollamos tratamientos innovadores para enfermedades graves como el cáncer y la osteoporosis, enfocándonos en necesidades médicas no cubiertas, llevando esperanza a millones de personas. 👥 Acercamos la biotecnología a quienes más la necesitan, mientras seguimos construyendo un futuro más saludable. 🌱🌟 #InnovaciónParaLaVida #SomosAmgen
-
-
Taking time to step away is important. That’s why, every summer, our U.S.-based teams take a week off to reconnect with what matters most and come back fully refreshed. It’s one of the many ways we invest in our people—learn more about Amgen benefits: https://bit.ly/3Hpvyus
-
Results from Amgen’s Phase 2 obesity study being presented during an expert-led symposium today at the American Diabetes Association 85th #ADASciSessions. The data evaluated MariTide in people living with obesity, with and without Type 2 diabetes. 🔗 Learn more: https://amgen.ly/4ngjzD4
-
Check out our highlights from the 85th #ADASciSessions so far. 👏 Thank you to the American Diabetes Association for bringing us together to explore the latest research and innovations advancing patient care. 🔍 Learn more about our scientific approach to addressing the unmet needs of people living with obesity, Type 2 diabetes and related conditions: https://amgen.ly/4k4Vlst.
-
At Amgen, your work fuels life-changing breakthroughs. No matter your role, you'll help deliver innovative medicines to patients worldwide. Discover more about a career with purpose: https://bit.ly/3HmIpAR
-
-
Step into the Amgen lab and meet the dedicated team who discovered our investigational medicine being studied in people living with #obesity, Type 2 diabetes and related conditions. 🔬🧬 Interested in learning more? We’ll be at the American Diabetes Association 85th #ADASciSessions starting Friday sharing an inside look at the science behind this molecule. 🎞️ 🔍 Watch the full video now: https://lnkd.in/gxQtVDx3